Stroma-Derived Interleukin-34 Controls the Development and Maintenance of Langerhans Cells and the Maintenance of Microglia
Top Cited Papers
Open Access
- 21 November 2012
- Vol. 37 (6), 1050-1060
- https://doi.org/10.1016/j.immuni.2012.11.001
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- PsoriasisAnnual Review Of Pathology-Mechanisms Of Disease, 2012
- Pivotal Role of Dermal IL-17-Producing γδ T Cells in Skin InflammationImmunity, 2011
- Interleukin-34 Selectively Enhances the Neuroprotective Effects of Microglia to Attenuate Oligomeric Amyloid-β NeurotoxicityThe American Journal of Pathology, 2011
- Skin-Resident Murine Dendritic Cell Subsets Promote Distinct and Opposing Antigen-Specific T Helper Cell ResponsesImmunity, 2011
- Pretransplant CSF-1 therapy expands recipient macrophages and ameliorates GVHD after allogeneic hematopoietic cell transplantationThe Journal of Experimental Medicine, 2011
- Langerhans cells are not required for epidermal Vγ3 T cell homeostasis and functionJournal of Leukocyte Biology, 2011
- An antibody against the colony-stimulating factor 1 receptor depletes the resident subset of monocytes and tissue- and tumor-associated macrophages but does not inhibit inflammationBlood, 2010
- Functional overlap but differential expression of CSF-1 and IL-34 in their CSF-1 receptor-mediated regulation of myeloid cellsJournal of Leukocyte Biology, 2010
- IL-34 and M-CSF share the receptor Fms but are not identical in biological activity and signal activationCell Death & Differentiation, 2010
- Pivotal Advance: Avian colony-stimulating factor 1 (CSF-1), interleukin-34 (IL-34), and CSF-1 receptor genes and gene productsJournal of Leukocyte Biology, 2010